Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China flag China · Delayed Price · Currency is CNY
20.87
+0.19 (0.92%)
Feb 4, 2026, 3:00 PM CST

SHA:603538 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
570.06585.43456.04791.94421.79236.52
Short-Term Investments
-----50.38
Trading Asset Securities
127.52154.44268.65217.38371.38133.14
Cash & Short-Term Investments
697.58739.87724.691,009793.16420.05
Cash Growth
-11.24%2.09%-28.20%27.25%88.83%-11.17%
Accounts Receivable
330.51331.32320.73187.59222.73165.03
Other Receivables
2452.8260.4528.4516.5366.18
Receivables
354.51384.14381.19216.04239.26231.21
Inventory
915.67773.76612.6594.42579.69454.71
Prepaid Expenses
-0.18----
Other Current Assets
106.4473.540.974.6190.2979.86
Total Current Assets
2,0741,9711,7591,8941,7021,186
Property, Plant & Equipment
1,8721,8881,9001,8021,6151,163
Long-Term Investments
338.74327.4315.32300.11319.59408.57
Goodwill
----22.7422.74
Other Intangible Assets
201.05203.4166.23142.73181.92201.93
Long-Term Deferred Tax Assets
35.2241.1642.67123.1833.2748.67
Long-Term Deferred Charges
49.3344.1155.2450.1641.0933.17
Other Long-Term Assets
177.12175.59184.34107.0185.8162.02
Total Assets
4,7484,6514,4244,4194,0013,126
Accounts Payable
632.93508.18390.99345.45220.92372.06
Accrued Expenses
38.6461.1561.7155.9850.6245.35
Short-Term Debt
545.18479.06486.72465.28425.87644.87
Current Portion of Long-Term Debt
151.4195.5453.8328.4475.6546.76
Current Portion of Leases
-2.972.263.293.52-
Current Income Taxes Payable
19.030.095.3656.9225.830.8
Current Unearned Revenue
160.26148.88153.09194.9281.0619.76
Other Current Liabilities
69.6190.11224.31211.94263.3625.73
Total Current Liabilities
1,6171,5861,3781,3621,1471,155
Long-Term Debt
584.74651.62743.96675.25727.31108.51
Long-Term Leases
11.0812.3515.6930.3428.03-
Long-Term Unearned Revenue
90.3183.1881.4870.5748.6727.16
Long-Term Deferred Tax Liabilities
21.0121.8213.59103.1267.3154.88
Other Long-Term Liabilities
4.854.854.854.854.854.85
Total Liabilities
2,3292,3602,2382,2462,0231,351
Common Stock
220.62218.75213.41213.38151.32149.61
Additional Paid-In Capital
673.19632.47583.45561.87587.21604.37
Retained Earnings
1,3941,3091,2471,271962.13819.6
Treasury Stock
-52.51-45.67-23.08-31.99-27.97-13.12
Comprehensive Income & Other
79.2277.8975.5971.1278.84.23
Total Common Equity
2,3152,1932,0962,0851,7511,565
Minority Interest
104.3898.789.4388.25227.02210.76
Shareholders' Equity
2,4192,2912,1862,1731,9791,775
Total Liabilities & Equity
4,7484,6514,4244,4194,0013,126
Total Debt
1,2921,3421,3021,2031,260800.14
Net Cash (Debt)
-594.82-601.66-577.77-193.29-467.21-380.09
Net Cash Per Share
-2.71-2.79-2.49-0.85-2.20-1.85
Filing Date Shares Outstanding
220.62218.75213.41213.38211.39209.01
Total Common Shares Outstanding
220.62218.75213.41213.38211.39209.01
Working Capital
457.16385.49381.11532.16555.5830.5
Book Value Per Share
10.4910.029.829.778.297.49
Tangible Book Value
2,1141,9891,9301,9421,5471,340
Tangible Book Value Per Share
9.589.099.049.107.326.41
Buildings
-872.69697.36593.92513.49478.89
Machinery
-1,2301,0871,054817.08807.1
Construction In Progress
-358.36576.39502.88733.82300.05
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.